Almeda Labs Assigned Patent for Amino Acid Formulations for Pancreatic Viability
Copyright © Targeted News Service, 2022
2022-01-24
Copyright © Targeted News Service, 2022
2022-01-24
ALEXANDRIA, Va., Jan. 24 -- Almeda Labs, Kansas City, Missouri, has been assigned a patent (No. 11,224,582, initially filed April 24, 2018) developed by two co-inventors for "amino acid formulations for pancreatic viability." The co-inventors are Stacy Tucker, Kansas City, Missouri, and Sushrutha Nagaraj, Kansas City, Missouri.
The full-text of the patent can be found at https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r . . .
The full-text of the patent can be found at https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r . . .